Production (Stage)
Utah Medical Products, Inc.
UTMD
$53.76
$0.100.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.71M | 9.16M | 10.01M | 10.40M | 11.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.71M | 9.16M | 10.01M | 10.40M | 11.34M |
| Cost of Revenue | 4.17M | 3.84M | 4.20M | 4.15M | 4.57M |
| Gross Profit | 5.54M | 5.32M | 5.80M | 6.25M | 6.77M |
| SG&A Expenses | 1.92M | 1.94M | 1.87M | 1.93M | 1.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.24M | 5.89M | 6.25M | 6.33M | 6.71M |
| Operating Income | 3.47M | 3.27M | 3.76M | 4.07M | 4.63M |
| Income Before Tax | 3.86M | 3.61M | 4.18M | 4.21M | 4.80M |
| Income Tax Expenses | 817.00K | 712.00K | 616.00K | 758.00K | 842.00K |
| Earnings from Continuing Operations | 3.04M | 2.90M | 3.56M | 3.45M | 3.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.04M | 2.90M | 3.56M | 3.45M | 3.96M |
| EBIT | 3.47M | 3.27M | 3.76M | 4.07M | 4.63M |
| EBITDA | 4.18M | 3.98M | 4.48M | 4.75M | 5.30M |
| EPS Basic | 0.92 | 0.86 | 1.02 | 0.98 | 1.09 |
| Normalized Basic EPS | 0.79 | 0.73 | 0.83 | 0.86 | 0.96 |
| EPS Diluted | 0.92 | 0.86 | 1.02 | 0.98 | 1.09 |
| Normalized Diluted EPS | 0.79 | 0.73 | 0.83 | 0.86 | 0.96 |
| Average Basic Shares Outstanding | 3.31M | 3.39M | 3.48M | 3.53M | 3.62M |
| Average Diluted Shares Outstanding | 3.31M | 3.39M | 3.48M | 3.53M | 3.62M |
| Dividend Per Share | 0.31 | 0.31 | 0.30 | 0.30 | 0.30 |
| Payout Ratio | 33.44% | 35.77% | 29.53% | 31.31% | 27.53% |